Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease
Authors
Keywords
-
Journal
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Volume 52, Issue 2, Pages 159-165
Publisher
Informa UK Limited
Online
2016-09-21
DOI
10.1080/00365521.2016.1239759
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Phosphatidylethanol Compared with Other Blood Tests as a Biomarker of Moderate Alcohol Consumption in Healthy Volunteers: A Prospective Randomized Study
- (2015) Stergios Kechagias et al. ALCOHOL AND ALCOHOLISM
- Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
- (2015) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Validity of the Lifetime Drinking History: A Comparison of Retrospective and Prospective Quantity-Frequency Measures
- (2015) Laura B. Koenig et al. Journal of Studies on Alcohol and Drugs
- Coffee, alcohol and other beverages in relation to cirrhosis mortality: The Singapore Chinese Health Study
- (2014) George Boon-Bee Goh et al. HEPATOLOGY
- Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
- (2014) Pierre Bedossa et al. HEPATOLOGY
- Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals
- (2013) Silvia Sookoian et al. GUT
- Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease
- (2013) Hellan K. Kwon et al. LIVER INTERNATIONAL
- Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis
- (2013) Kiran Bambha et al. LIVER INTERNATIONAL
- The global NAFLD epidemic
- (2013) Rohit Loomba et al. Nature Reviews Gastroenterology & Hepatology
- NAFLD, NASH and liver cancer
- (2013) Gregory A. Michelotti et al. Nature Reviews Gastroenterology & Hepatology
- Monitoring of the Alcohol Biomarkers PEth, CDT and EtG/EtS in an Outpatient Treatment Setting
- (2012) Anders Helander et al. ALCOHOL AND ALCOHOLISM
- Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
- (2012) Pierre Bedossa et al. HEPATOLOGY
- Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD)
- (2012) Winston Dunn et al. JOURNAL OF HEPATOLOGY
- Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study
- (2012) D. Di Giuseppe et al. BMJ-British Medical Journal
- Effects of moderate red wine consumption on liver fat and blood lipids: a prospective randomized study
- (2011) Stergios Kechagias et al. ANNALS OF MEDICINE
- The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
- (2010) Mustafa S. Ascha et al. HEPATOLOGY
- Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome
- (2009) Ali Abid et al. JOURNAL OF HEPATOLOGY
- Role of leisure-time physical activity in nonalcoholic fatty liver disease: A population-based study
- (2008) Shira Zelber-Sagi et al. HEPATOLOGY
- Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease
- (2008) Winston Dunn et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started